Stoneridge Investment Partners’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,410
| Closed | -$56K | – | 128 |
|
|
2019
Q4 | $56K | Hold |
1,410
| – | – | 0.02% | 131 |
|
|
2019
Q3 | $35K | Hold |
1,410
| – | – | 0.01% | 125 |
|
|
2019
Q2 | $50K | Buy |
+1,410
| New | +$50K | 0.02% | 112 |
|
|
2018
Q2 | – | Sell |
-5,085
| Closed | -$287K | – | 144 |
|
|
2018
Q1 | $287K | Sell |
5,085
-1,993
| -28% | -$112K | 0.05% | 166 |
|
|
2017
Q4 | $351K | Hold |
7,078
| – | – | 0.06% | 157 |
|
|
2017
Q3 | $539K | Sell |
7,078
-1,223
| -15% | -$93.1K | 0.08% | 120 |
|
|
2017
Q2 | $781K | Sell |
8,301
-12,903
| -61% | -$1.21M | 0.12% | 124 |
|
|
2017
Q1 | $1.68M | Buy |
21,204
+173
| +0.8% | +$13.7K | 0.23% | 134 |
|
|
2016
Q4 | $1.75M | Hold |
21,031
| – | – | 0.24% | 129 |
|
|
2016
Q3 | $2.35M | Buy |
21,031
+6,469
| +44% | +$723K | 0.34% | 107 |
|
|
2016
Q2 | $1.62M | Sell |
14,562
-18,012
| -55% | -$2M | 0.24% | 127 |
|
|
2016
Q1 | $3.41M | Sell |
32,574
-15,358
| -32% | -$1.61M | 0.5% | 64 |
|
|
2015
Q4 | $3.87M | Buy |
47,932
+1,466
| +3% | +$118K | 0.52% | 58 |
|
|
2015
Q3 | $3.22M | Buy |
46,466
+2,985
| +7% | +$207K | 0.45% | 63 |
|
|
2015
Q2 | $4.26M | Buy |
43,481
+22,211
| +104% | +$2.18M | 0.53% | 49 |
|
|
2015
Q1 | $2.08M | Buy |
21,270
+292
| +1% | +$28.6K | 0.24% | 131 |
|
|
2014
Q4 | $2.31M | Buy |
20,978
+11,007
| +110% | +$1.21M | 0.3% | 112 |
|
|
2014
Q3 | $1.18M | Buy |
+9,971
| New | +$1.18M | 0.17% | 149 |
|